Uncertainties in measurement of uncertainty measurements: A commentary from the perspective of a specialist haemostasis laboratory

Australian Journal of Medical Science

Volumn 27, Issue 2, 2006, Pages 72-83

  Favaloro, Emmanuel J ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b Sydney West Area Health Service NSW Health   (Australia)

Author keywords

Bias; Measurement of uncertainty; Quantitative testing; Random error; Systematic error; Total error; Uncertainty of measurement; Variation

Indexed keywords

ANALYTICAL ERROR; CALIBRATION; EPIDEMIOLOGY; HEMOSTASIS; HUMAN; LABORATORY; MEASUREMENT; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; QUANTITATIVE ASSAY; RANDOM ERROR; REVIEW; SYSTEMATIC ERROR; UNCERTAINTY;

EID: 33746138960     PISSN: 10381643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Editorial (Badrick, T attribution in Aust J Med Sci; 27:3) 2005. Uncertainty of Measurement. Aust J Med Sci 2005; 26: 139.
2. Cook RR. 2002. Assessment of Uncertainties of Measurement for Calibration and Testing Laboratories. Published by National Association of Testing Authorities (NATA), Australia. 2nd ed.
3. Dimech W, Francis B, Roberts G, Chappel R, Kox J. 2005. A proposed approach to estimating uncertainty of measurement in serological assays. Aust J Med Sci; 26: 58-64.
4. Favaloro EJ, Mehrabani PA, and Koutts J. 1997. Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different vWF assays and assay conditions. Clin Appl Thromb/Hemost; 3:110-118.
5. Favaloro EJ, Mirochnik O, & McDonald D. 1999a. Functional Activated Protein C Resistance Assays: correlation with Factor V DNA analysis is better with RVVT- than APTT- based assays. Br J Biomed Sci; 56: 23-33.
6. Favaloro EJ, Silvestrini R, and Mohammed A. 1999b. Clinical Utility of Anticardiolipin Antibody Assays: High inter-laboratory variation and limited consensus by participants of external Quality Assurance Programs signals a cautious approach. Pathology; 31:142-147.
7. Favaloro EJ. 2000. Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease CVWD), and discrimination of VWD subtypes, depends on collagen source. Thromb Haemost; 83: 127-135.
8. Favaloro EJ, Orsag I, Bukuya M, & McDonald D. 2002a. A nine-year retrospective assessment of laboratory testing for Activated Protein C Resistance: Evolution of a novel approach to thrombophilia investigations. Pathology; 34: 348-55.
9. Favaloro EJ, Silvestrini R. 2002b. Assessing the utility of anticardiolipin antibody assays: A cautious approach is suggested by high variation and limited consensus in multi-laboratory testing. Am J Clin Pathol; 118: 548-557.
10. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. 2005a. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S and antithrombin deficiency and the potential high risk of a false positive diagnosis. Lab Haematol;11:174-184.
11. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JWC. 2005b. Reassessment of ABO-blood group, gender and age on laboratory parameters used to diagnose von Willebrand Disorder (VWD): Potential influence on the diagnosis versus the potential association with risk of thrombosis. Am J Clin Pathol; 124: 910-917.
12. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. 2005c. Cross-laboratory audit of normal reference ranges and assessment of ABO-blood group, gender and age on detected levels of plasma coagulation factors. Blood Coag Fibrinolysis; 16:597-605.
13. Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Duncan E, Smith J, Exner T, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology). 2005d. Multi-laboratory testing of thrombophilia: Current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program in Haematology. Sem Thromb Hemost; 31: 49-58.
14. Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Thom J, Baker R, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology). 2005e. Laboratory diagnosis of von Willebrand Disorder: Use of multiple functional assays reduces diagnostic error rates. Lab Hematol; 11: 91-97.
15. Favaloro EJ, Wong R, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thompson P. 2005f. A multi-laboratory peer-assessment quality assurance program based evaluation of anti-cardiolipin antibody, and beta-2-glycoprotein-l antibody, testing. Sem Thromb Hemost; 31: 73-84.
16. Linnet K. 1999 Necessary sample size for method comparison studies based on regression analysis. Clin Chem: 882-894.
17. Mina A. 2005A New Model to Calculate Uncertainty of Measurement for Quantitative Assays in Clinical Pathology Laboratories. Aust J Med Sci; 26: 140-149.
18. Mohammed A, Mehrabani PA, Coombs R, Molesworth L, Favaloro EJ. 1997. The MDA-180 Coagulation Analyser: A laboratory evaluation. Pathology; 29: 176-183.
19. National Association of Testing Authorities. Australia (NATA). 2003. Technical circular: Uncertainty of Measurement in Biological, Forensic, Medical and Veterinary Testing. Available at: http://www.nata.asn.au/publications/ downloads/TechCirc2.pdf (Last accessed 23/11/05).
20. National Pathology Accreditation Advisory Council (NPAAC) 2005. Standard and Guidelines for the Estimation of Uncertainty of Measurement. available at: http://www.health.gov.au/internet/wcms/Publishing.nsf/Content/ health-npaac-publication.htm. Accessed 9/12/05.
21. RCPA: Uncertainty of Measurement Guideline 2004. Royal Collage of Pathologists of Australasia (Guideline No: 2/2004). Available from the RCPA Website (www.rcpa.edu.au); last accessed 23/11/05.
22. White GH, Farrance I (on behalf of the AACB Uncertainty of Measurement Working Group). 2004. Uncertainty of Measurement in Quantitative Medical Testing: A laboratory implementation guide. Clin Biochem Rev; 25 (Suppl (ii)):S1-S24.
23. Wong RCW, Favaloro EJ, Pollock W, Wilson RJ, Hendle MJ, Adelstein S, Baumgart K, Homes P, Smith S, Steele RH, Sturgess A, Gillis D. 2004. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology; 36: 182-192.